Asarina Pharma AB (publ) (ASRPF) Stock Analysis
DELISTED
What happened to Asarina Pharma AB (publ) (ASRPF) stock?
Asarina Pharma AB (publ) (ASRPF) no longer trades on public markets. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
P/E 265.59 means the share price is 265.59 times one year of earnings per share. Market cap $41.8M is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Asarina Pharma AB (publ) (ASRPF). Asarina Pharma AB (publ) is a Swedish biopharmaceutical company focused on developing novel treatments for brain-related conditions, particularly those affecting women.
Last analyzed: Mar 17, 2026Asarina Pharma AB (publ) (ASRPF) Healthcare & Pipeline Overview
ASRPF OTC Market Information
ASRPF trades on the OTC Other market tier of OTC Markets.
- OTC Tier: OTC Other
More about this archive record
Can I still buy ASRPF shares?
No. ASRPF stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for ASRPF elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before ASRPF stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Asarina Pharma AB (publ). An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.